S&P Global Ratings projects Glenmark Pharmaceuticals will achieve a net cash positive position following its licensing agreement with AbbVie Inc. This deal, concerning ISB 2001, is expected to ...

Glenmark Pharma's licensing deal with AbbVie will make it cash positive, improving its financial position and liquidity, according to S&P.

Glenmark Pharmaceuticals is set to become net cash positive through its licensing agreement with AbbVie Inc. This move aims ...

India and the US are key trade partners, but a formal trade deal is still missing. As talks progress, the big question is: ...

Despite making a sombre start to the year with nearly 5% corrections, Nifty 50 has not only recovered but increased by nearly ...

ArcelorMittal Nippon Steel India (AM/NS India) has commissioned a cutting-edge Continuous Galvanising Line (CGL) for ...

29 April 2025 EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical contribution | Court had earlier overturned a first-instance decision allowing an ...